Skip to main content

Table 6 Does the risk assessment tool indicate specific monitoring approaches to be used to mitigate the risks identified? (n = 22 for CTIMPs, n = 19 for non-CTIMPs)

From: An evaluation of risk-based monitoring in pragmatic trials in UK Clinical Trials Units

Yes 13 9
No 9 10
  1. Abbreviation: CTIMP Clinical Trial of an Investigational Medicinal Product